Here are five points:
1. On Feb. 18, BMO Capital analysts lowered LDR Holding’s price target from $28 to $23.
2. On Feb. 18, RBC Capital analysts reaffirmed the company’s “outperform rating.”
3. On Feb. 22, LDR Holding exchanged 491,249 shares.
4. The company traded down 1.38 percent on Feb. 22.
5. LDR Holding’s 50-day moving average is $19.93 and its 200-day moving average is $28.49.
More articles on devices:
26 spine devices receive FDA 510(k) clearance in January
Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, Smith & Nephew: Who had the best 2015? 32 things to know
Cervical artificial disc replacement & lateral spine surgery: 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
